Post-Bariatric Patients See More Benefits With Semaglutide vs ...

MedPage Today - 08 Mar 2023
Semaglutide users also more likely to experience weight loss, retrospective study suggests.

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

CNN - 06 Nov 2024
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns ...

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Reuters.com - 06 Nov 2024
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died ...

Has semaglutide transformed treatment of diabetes and obesity in India?

The Hindu - 08 Nov 2024
Has semaglutide transformed treatment of diabetes and obesity in India? ...

FDA adds warning to Ozempic, Wegovy

The Dallas Morning News - 07 Nov 2024
FDA adds warning to Ozempic, Wegovy ...

Does Semaglutide Increase Risk for Optic Neuropathy?

Medscape - 08 Nov 2024
Does Semaglutide Increase Risk for Optic Neuropathy? ...

What can't Ozempic and other weight loss drugs cure?

Quartz - 06 Nov 2024
What can't Ozempic and other weight loss drugs cure? ...

GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints

BioWorld Online - 07 Nov 2024
GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints ...

Counterfeit weight loss drugs sold online, feeding demand for cheaper options

CBS News - 08 Nov 2024
Counterfeit weight loss drugs sold online, feeding demand for cheaper options ...

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

News-Medical.Net - 08 Nov 2024
Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes ...

Ten die and 100 sent to hospital after taking off-brand Ozempic

The Times - 06 Nov 2024
Ten die and 100 sent to hospital after taking off-brand Ozempic ...

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

Pharmacy Times - 08 Nov 2024
Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation ...

Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029

GlobeNewswire - 08 Nov 2024
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029 ...

Semaglutide